Integrated Machine Learning Algorithms for Stratification of Patients with Bladder Cancer

IF 2.4 3区 生物学 Q3 BIOCHEMICAL RESEARCH METHODS
Yuanyuan He, Haodong Wei, Siqing Liao, Ruiming Ou, Yuqiang Xiong, Yongchun Zuo, Lei Yang
{"title":"Integrated Machine Learning Algorithms for Stratification of Patients with Bladder Cancer","authors":"Yuanyuan He, Haodong Wei, Siqing Liao, Ruiming Ou, Yuqiang Xiong, Yongchun Zuo, Lei Yang","doi":"10.2174/0115748936288453240124082031","DOIUrl":null,"url":null,"abstract":"Background: Bladder cancer is a prevalent malignancy globally, characterized by rising incidence and mortality rates. Stratifying bladder cancer patients into different subtypes is crucial for the effective treatment of this form of cancer. Therefore, there is a need to develop a stratification model specific to bladder cancer. Purpose: This study aims to establish a prognostic prediction model for bladder cancer, with the primary goal of accurately predicting prognosis and treatment outcomes. objective: This study aims to establish a prognostic prediction model for bladder cancer, with the primary goal of accurately predicting prognosis and treatment outcomes. Methods: We collected datasets from 10 bladder cancer samples sourced from the Gene Expression Omnibus (GEO), the Cancer Genome Atlas (TCGA) databases, and IMvigor210 dataset. The machine learning based algorithms were used to generate 96 models for establishing the risk score for each patient. Based on the risk score, all the patients was classified into two different risk score groups. Results: The two groups of bladder cancer patients exhibited significant differences in prognosis, biological functions, and drug sensitivity. Nomogram model demonstrated that the risk score had a robust predictive effect with good clinical utility. Conclusion: The risk score constructed in this study can be utilized to predict the prognosis, response to drug treatment, and immunotherapy of bladder cancer patients, providing assistance for personalized clinical treatment of bladder cancer. other: None","PeriodicalId":10801,"journal":{"name":"Current Bioinformatics","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioinformatics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.2174/0115748936288453240124082031","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Bladder cancer is a prevalent malignancy globally, characterized by rising incidence and mortality rates. Stratifying bladder cancer patients into different subtypes is crucial for the effective treatment of this form of cancer. Therefore, there is a need to develop a stratification model specific to bladder cancer. Purpose: This study aims to establish a prognostic prediction model for bladder cancer, with the primary goal of accurately predicting prognosis and treatment outcomes. objective: This study aims to establish a prognostic prediction model for bladder cancer, with the primary goal of accurately predicting prognosis and treatment outcomes. Methods: We collected datasets from 10 bladder cancer samples sourced from the Gene Expression Omnibus (GEO), the Cancer Genome Atlas (TCGA) databases, and IMvigor210 dataset. The machine learning based algorithms were used to generate 96 models for establishing the risk score for each patient. Based on the risk score, all the patients was classified into two different risk score groups. Results: The two groups of bladder cancer patients exhibited significant differences in prognosis, biological functions, and drug sensitivity. Nomogram model demonstrated that the risk score had a robust predictive effect with good clinical utility. Conclusion: The risk score constructed in this study can be utilized to predict the prognosis, response to drug treatment, and immunotherapy of bladder cancer patients, providing assistance for personalized clinical treatment of bladder cancer. other: None
用于膀胱癌患者分层的集成机器学习算法
背景:膀胱癌是一种全球流行的恶性肿瘤,发病率和死亡率不断上升。将膀胱癌患者分为不同亚型对有效治疗这种癌症至关重要。因此,有必要开发一种专门针对膀胱癌的分层模型。目的:本研究旨在建立膀胱癌预后预测模型,主要目的是准确预测预后和治疗效果:本研究旨在建立膀胱癌预后预测模型,主要目的是准确预测预后和治疗效果。方法:我们收集了 10 个膀胱癌患者的数据集:我们从基因表达总库(GEO)、癌症基因组图谱(TCGA)数据库和 IMvigor210 数据集中收集了 10 个膀胱癌样本的数据集。利用基于机器学习的算法生成了 96 个模型,为每位患者确定了风险评分。根据风险评分,所有患者被分为两个不同的风险评分组。结果显示两组膀胱癌患者在预后、生物功能和药物敏感性方面存在显著差异。提名图模型表明,风险评分具有很强的预测效果和良好的临床实用性。结论本研究构建的风险评分可用于预测膀胱癌患者的预后、对药物治疗的反应和免疫治疗,为膀胱癌的个性化临床治疗提供帮助。 其他:无
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Bioinformatics
Current Bioinformatics 生物-生化研究方法
CiteScore
6.60
自引率
2.50%
发文量
77
审稿时长
>12 weeks
期刊介绍: Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science. The journal focuses on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信